
Sign up to save your podcasts
Or
This subgroup analysis from the MASTER-DAPT trial demonstrates that in high-bleeding risk patients with acute or recent myocardial infarction it is safe to stop DAPT 1 month after stenting and that this strategy provides a reduction in bleeding risk.
In this interview, Pieter C. Smits MD, PhD, FESC and Sidney C. Smith Jr. MD, MACC, with Jeffrey Hsu MD, PhD, discuss a recent piece from JACC: Abbreviated Antiplatelet Therapy after Coronary Stenting in Patients with Myocardial Infarction at High Bleeding Risk.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
3.8
4747 ratings
This subgroup analysis from the MASTER-DAPT trial demonstrates that in high-bleeding risk patients with acute or recent myocardial infarction it is safe to stop DAPT 1 month after stenting and that this strategy provides a reduction in bleeding risk.
In this interview, Pieter C. Smits MD, PhD, FESC and Sidney C. Smith Jr. MD, MACC, with Jeffrey Hsu MD, PhD, discuss a recent piece from JACC: Abbreviated Antiplatelet Therapy after Coronary Stenting in Patients with Myocardial Infarction at High Bleeding Risk.
Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL
127 Listeners
314 Listeners
160 Listeners
854 Listeners
478 Listeners
22 Listeners
31 Listeners
91 Listeners
134 Listeners
1,085 Listeners
38 Listeners
174 Listeners
413 Listeners
33 Listeners
127 Listeners